Isoelectrofocusing of nonionic-detergent-disrupted flaviviruses separated the envelope glycoprotein of 53,000 to 58,000 daltons and the nucleocapsid protein of 14,000 daltons. The envelope protein and nucleocapsid protein were isolated at isoelectric points of pI 7.8 and 10.3, respectively. The antigenic determinants of St. Louis encephalitis, Japanese encephalitis, and dengue virus envelope and nucleocapsid proteins were examined by solid-phase competition radioimmunoassay. By the appropriate selection of antiserum and competing proteins, it was possible to distinguish type-specific, complex-reactive and flavivirus groupreactive antigenic determinants. The envelope glycoproteins of St. Louis encephalitis, Japanese encephalitis, and dengue viruses were found to contain each of these three classes of antigenic determinants. Most of the determinants on the envelope protein were type specific, some were complex reactive, and a small fraction were flavivirus group reactive. The nucleocapsid protein contained only flavivirus group-reactive antigenic determinants.
specific antigens, which distinguish between different flaviviruses, have been studied by virus neutralization (7, 8, 18, 25, 40, 41) and hemagglutination inhibition (HI) with adsorbed sera (7) (8) (9) . Complex-reactive antigens can be demonstrated by complement fixation (CF), immunodiffusion, or neutralization tests (7, 8, 13, 18, 25, 27, 40, 43) . Japanese encephalitis (JE), St. Louis encephalitis (SLE) and West Nile viruses form one serocomplex of viruses, which share antigens that are immunologically distinct from viruses in the dengue or yellow fever serocomplexes (5) . Each virus within a complex can be considered as a serotype containing type-specific determinants that react only with homologous antibody and complexreactive antigens common to viruses within the complex (7) (8) (9) . Antigenic cross-reactivity among the flaviviruses appears to be due to group-reactive antigens shared by all flaviviruses. These broadly reactive determinants have been demonstrated in CF tests with reagents that do not differentiate between different flaviviruses but clearly distinguish between togaviruses of the alpha-virus and flavivirus genera (4) .
The major envelope protein of JE and SLE viruses, released from the visions or infected cells after detergent treatment, binds to erythrocytes (17, 34) , reacts with antibodies in the CF and immunodiffusion tests (13, 17, 24, 42) , and induces the formation of neutralizing antibodies (12, 26, 27) . In both CF and immunodiffusion tests, this isolated glycoprotein is serologically broadly cross-reactive (19, 26, 27) . Dengue virus envelope glycoprotein isolated by concanavalin A chromatography is type specific by CF and does not react with neutralizing antibodies (34) . We now report additional studies on the antigenic properties of purified flavivirus proteins: the large glycosylated envelope protein with a molecular weight of 53,000 to 58,000, and the nucleocapsid protein with a molecular weight of about 14 ,000 (32-39, 41, 42) . By using 125I-labeled purified protein antigens in an inhibition solid-phase radioimmunoassay, we were able to analyze these viral components for each of their antigenic determinants. The envelope glycoprotein contains multiple antigenic determinants: strongly reactive type-specific and complex-reactive antigens, as well as the flavivirus group determinants. The flavivirus nucleocapsid protein is broadly cross-reactive within the flavivirus group, and its serological specificity appears comparable to group-reactive proteins of the alphaviruses (10, 11) and influenzavirus (21, 30) .
viruses were used: dengue 1 (DEN-1) (Hawaii), dengue 2 (DEN-2) (TR-1751), dengue 3 (DEN-3) (H-87), and dengue 4 (DEN-4) (H-241). Milligram quantities of SLE, JE, and dengue viruses were propagated in roller bottle cultures of porcine kidney (PS) cells or rhesus monkey kidney (LLC-MK2) cells as previously described (38) .
Preparation of purified virus. Tracer amounts of virus labeled with radioactive amino acids were prepared by incubating infected cells in medium 199 containing 1/10 the normal concentration of amino acids and 5% dialyzed calf serum. Mixtures of radioactive amino acids (New England Nuclear Corp.) were added to a final concentration of 10 ,uCi/ml for 3H-labeled amino acids or 2 ACi/ml for "4C-labeled amino acids at 12 h postinfection. After 48 h, the virus-containing media were pooled and clarified by centrifugation at 10,000 x g for 30 min. All purification procedures were carried out at 40C. The virus was concentrated by glycol precipitation (23) and collected by centrifugation at 10,000 x g for 30 min.
The precipitates were suspended in one-fifth the original volume of TNE buffer (0.01 M Tris [pH 8.01, 0.15 M NaCl, and 0.001 M EDTA), homogenized in a tissue grinder, and clarified by centrifugation at 5,000 x g for 10 min. The resulting supernatant fluid was layered over a discontinuous sucrose gradient (15 ml of 15% [wt/vol] sucrose in TNE buffer resting on 5 ml of 65% [wt/vol] sucrose in the same buffer) and centrifuged at 80,000 x g for 3.5 h in a Spinco SW27 rotor. The visible virus band at the interface of the two sucrose solutions was collected, diluted with an equal volume of TNE buffer, and layered on a 25-ml gradient of potassium tartrate (48%, wt/vol) and glycerol (30% vol/vol) in TNE buffer (24) . Virus preparations were centrifuged to equilibrium at 25,000 rpm for 15 h, and the virus band was removed and recycled through a second similar isopycnic centrifugation. The virus band was collected and dialyzed for 3 h against 0.2 M Tris buffer (pH 8.0) to remove the potassium tartrate and glycerol.
Isoelectric focusing of viral structural proteins. Ten milligrams ofpurified flavivirus in 2 ml of0.2 M Tris buffer (pH 8.0) was mixed with 100 mg of Triton N-101 and 0.1 M dithiothreitol, and the mixture was held at room temperature for 15 min. The solubilized virus was isoelectric focused on an LKB-8101 (110 Ml) Ampholine column (LKB-Produckter AB). Linear 0 to 65% sucrose gradients were prepared with ultrapure sucrose (Schwarz/Mann), 1% Ampholine (LKB-Produckter AB), and 0.5% Triton N-101. Application of the virus sample to the gradient and conditions of electrophoresis were essentially the same as described by Dalrymple et al. (10) . Column fractions were collected and immediately analyzed for pH and radioactivity. Peak fractions were pooled, dialyzed against 0.05 M Tris (pH 8.0) for 3 to 4 days to remove sucrose and ampholytes and to reduce the detergent concentration, and stored at -70°C. The protein concentration of the antigen preparations was determined on acetone-precipitated samples (21) and analyzed for purity by polyacrylamide gel electrophoresis (PAGE).
SDS-PAGE. The discontinuous polyacrylamide gel system used was basically that described by Laemmli (20) . The resolving gel contained 13% (wt/ vol) acrylamide and 0.62% (wt/vol) NN1-diallytartardiamide. Before electrophoresis, proteins were concentrated by acetone precipitation, suspended in sodium dodecyl sulfate (SDS) sample buffer (0.0625 M Tris, pH 6.8; 1% SDS, 10% glycerol; 0.001% bromophenol blue; 0.1% 2-mercaptoethanol), and solubilized by heating at 100°C for 10 min. Gels were manually sliced into 1-mm sections, dispensed into vials, and incubated in scintillation cocktail at 56°C for 15 h. The liquid scintillation counting cocktail consisted of 4% NCS (Amersham Searle Corp.) and 0.4% Omnifluor (New England Nuclear Corp.) in scintillation-grade toluene.
Solid-phase radioimmunoassay and antiserum preparation. The solid-phase microtiter SPRIA test for detection of flavivirus antibodies was previously described (38) . This procedure was been modified to provide a sensitive inhibition test in which antibody sites are blocked by increasing amounts ofunlabeled antigen before the addition of a constant amount of 125I-labeled antigen. Seventy-five microliters of rabbit antivirus immunoglobulin G (IgG) containing 500 Fg of protein in 0.05 M sodium carbonate-bicarbonate buffer (pH 9.6) was placed in the wells of each Linbro U-bottom polyvinyl microtiter plate (Bellco Glass Inc.) that had been treated for cell culture growth. The plates were then incubated at 37°C for 2 h, the unadsorbed globulin was removed by aspiration, and the microtiter well was washed twice with phosphate-buffered saline (PBS) (12). To each well was then added 200 ,u of PBS that contained 10% normal rabbit serum, and the plate wasincubated for 1 h at 37°C. The unadsorbed rabbit serum was removed by aspiration, and the wells were washed three times. In the inhibition test, 50 ,ul of unlabeled antigen diluted in PBS was added in increasing amounts of antibody-coated wells, which were then incubated 37°C for 3 h and refrigerated at 4°C for 4 h. The unbound antigen was removed, and each well was charged with 50 ,g of 1251-labeled antigen in 50 )A of PBS containing 2% rabbit serum.
The plates were incubated at 4°C overnight and washed 10 times with PBS, and the microtiter wells were separated with scissors and placed in scintillation vials. Radioactivity was measured in a Beckman 310 spectrometer. The average count from three replicate samples was determined, and the radioactivity bound without inhibitor minus the radioactivity bound with inhibitor was divided by the counts bound in the absence of inhibitor and multiplied by 100 to obtain the percent binding.
Hyperimmune mouse ascitic fluids were prepared by the method of Brandt et al. (2) . Rabbit antisera to viral antigens were prepared as previously described (39) . Rabbit anti-viral IgG globulin used to coat the solid phase was prepared by precipitation from whole serum with ammonium sulfate and chromatography on DEAE-cellulose (15, 39) . Column fractions that contained IgG were concentrated to the original serum volume by ultrafiltration (Diaflo XM-50) and stored at -70°C.
Iodination of virus and isolated viral components. Virions and viral structural proteins isolated by isoelectric focusing were extrinsically iodinated VOL. 22 (500 uCi/500 1.l). After incubation at 250C for 15 min, a second portion of H,02 was added and the reaction was continued for an additional 15 min. After iodination, the free iodine was separated from the antigens by filtration through a Sephadex G-25 column equilibrated in PBS with 0.0% Triton N-101. The peak fractions were pooled, and a portion was removed for trichloroacetic acid precipitation and counting of radioactivity.
Protein determination. Protein was determined by the modified Lowry method (22), with crystalline bovine serum albumin used as a standard.
RESULTS
Structural protein nomenclature. Flaviviruses contain three structural proteins originally designated V-1, V-2, and V-3 (Table 1) by various authors (33, 35, 39, 41, 42) . Although this nomenclature does provide a general identification, it fails to describe any of the now known chemical, physical, or immunological properties of the proteins. To more completely describe the flavivirus structural proteins used in this study, we designate the envelope glycoproteins by the letters "gp" followed by the molecular weight in thousands. Virus abbreviations approved by the American Committee on Arthropod-Borne Viruses are used to designate individual viruses (14) . The envelope glycoprotein of SLE virus is thus designated SLE gp 53 (E), and analogous JE and dengue virus subunits are designated JE gp 58 (E) and DEN gp 58 (E), respectively. Similarly, the nucleocapsid component shall be designated "p" 14 (N); SLE p 14 (N), JE p 14 (N), and DEN p 14 (N). The nonglycosylated membrane proteins of the flavivirus will be designated "p" 7 (M). Such a system of nomenclature is now widely used to describe proteins of the oncogenic RNA viruses and provides a concise and unambiguous method of describing viral structural compo-
Isoelectric focusing of disrupted SLE virions. Radioactive SLE virions labeled with 3H-amino acids disrupted with Triton N-101 and dithiothreitol were isoelectrically focused in a pH-range ampholine gradients of 5 to 8 and 9 to 11, respectively, without any substantial 7.8 and 10.3, respectively ( Fig. 1) . A minor peak of radioactivity was observed at pH 3.8. The two major peaks of radioactive protein focused at pH 7.8 and 10.3 were refocused on narrowpH-range ampholine gradients of 5 to 8 and 9 to 11, respectively, without any substantial change in their isoelectric point.
For identifying the solubilized SLE viral proteins that were separated by isoelectric focusing, portions of protein that focused at pI 7.8 Fig. 4 : (i) 5 ,ug of JE gp 58 protein, which gave maximal competition for the complex-reactive antibody, was approximately 100-fold greater than the amount of SLE gp 53 protein required for 53% competition of all antibodies; and (ii) the maximal competition by JE and DEN-2 virus proteins was about 30 and 10%, respectively.
To exclude the possibility that the JE and dengue antigens were immunologically inactive, we analyzed the competing proteins in a heterologous assay with labeled SLE indicator, using the same labeled JE and DEN-2 antigens and JE virus antiserum in place of SLE serum. In this system, only the group and complexreactive determinants that JE gp 58 and SLE gp 53 antigen share should be reactive. Both SLE and JE gave equal and complete competition (Fig. 5) , demonstrating the presence of comparable amounts of complex-reactive determinants, whereas DEN-2 gp 58 was not equally competitive. These results indicate that DEN-2 gp 58 contains few JE-SLE complex antigens but does exhibit flavivirus group antigens, which block the binding of indicator SLE antigen at high dengue competing protein concentrations.
To extend these findings and compare the JE and SLE proteins, we performed reciprocal experiments with 125I-labeled JE gp 58 as the antigen and SLE and dengue glycoprotein as competitors. The results were analogous to those shown in the previous experiment (Fig.  5) . Only a fraction of the anti-JE virus antibodies bound SLE gp 53 protein, and approximately threefold more SLE antigen than JE protein was required for 50% of the maximal observed competition. DEN-2 antigen at a concentration of 10 ,ug/ml bound less than 6% of the JE-SLE complex specific antibody present in the JE serum. These experiments were repeated by adding Triton N-101-degraded virions as a competitor instead of purified envelope proteins. The results of these experiments were essentially the same as those shown in Fig. 4 , except that 10-to 20-fold more purified viral polypeptide than dissociated virus was required to inhibit 50% maximal binding by the indicator SLE gp 53. This indicated either that the purified antigens were not as reactive as solubilized virus, or that other antigenic determinants on the membrane and nucleocapsid proteins were perhaps participating in the reaction. The data from these experiments did not permit resolution of these alternatives.
The envelope glycoproteins were further characterized by testing the competition of these proteins from different strains ofJE virus and serotypes of dengue virus. Antigenic differences among the Nakayama, JaGar-01, and Yokoshiba strains of JE virus were analyzed by testing competition in homologous assay systems containing 12I-labeled Nakayama gp 58 protein and homologous antiserum. The complex and type-specific antigens should be distinguished since inhibitions greater than that of SLE gp 53 would indicate type-specific determinants common to the different JE virus strains. Failure to compete for all ofthe antibody should similarly indicate the presence of strain-specific determinants.
The Nakayama, JaGAr-Ol, and Yokoshiba gp 58 proteins all showed strong competition for antibodies to the Nakayama protein (Fig. 6A) , thus confirming the presence of type-specific determinants on the JE gp 58 protein that are shared by the different JE virus strains. Since there was an almost complete competition when a sufficiently high concentration of heterologous JE virus proteins was used, it appears that the majority of antibodies in the Nakayama serum were directed at the type-specific determinants. It was evident, however, that among the different JE virus strains the concentration of type-specific determinants or the affinity of antibodies for these determinants in the Nakayama serum was not the same since increased amounts of protein were required for competition in the order of Nakayama, JaGAr-01, and Yokoshiba.
Analogous results were obtained from an experiment with antiJaGAr-O1 serum and heterologous '25I-labeled Nakayama gp 58 protein (Fig. 6A) . In this case, the assay measured determinants common to the three viruses, and it would be expected that they would give similar competition curves. It appears that deterninants common to the Nakayama and JaGAr-O1 viruses were not equally shared with the Yokoshiba virus since a greater concentration of these viral proteins was required for complete competition. Differences among the type-specific determinants present on the JE virus gp 58 protein are either in the number oftype-specific determinants per molecule or in their affinity for the antibody to Nakayama gp 53 protein.
Experiments were attempted to determine whether the concentration of complex-reactive determinants was the same on gp 53 proteins from the different JE virus strains. A heterologous inhibition test was used in which each of the gp 58 proteins from the three JE virus strains was tested for its ability to inhibit the SLE antibody-Nakayama envelope protein cross-reaction (Fig. 7) . Each JE virus gp 58 protein was equally effective as a competitor in the heterologous assay measuring complex-reactive antigenic determinants. These results suggest that differences among the JE virus strains detected in the homologous competition assay (Fig. 6A and B In experiments carried out with the homologous assay system, 125I-labeled DEN-2 gp 58 protein and anti-DEN-2 serum, the effects of competition by DEN-1, -2, and -3, and -4 were compared with the standard competition given by DEN-2 gp 58. As seen in Fig. 8A , a comparison of the DEN-2 protein competition with that of indicates that 20-fold more DEN-4 glycoprotein than DEN-2 glycoprotein was required to produce a 50% maximal competition with the 125I-labeled DEN-2 indicator. By comparison, 18-fold more unlabeled DEN-1 protein and 2-fold more unlabeled DEN-3 protein were required to achieve 50% maximal competition than were required for the homologous DEN-2 reaction. SLE virus gp 53 protein at a concentration of 50 ug inhibited the homologous DEN-2 precipitation by 12%, indicating the reaction of flavivirus reactive determinants. It thus appears that the minor antigenic component present in the DEN-2 envelope is a group-reactive determinant that is also present in SLE and JE viruses. Complex and type-specific determinants of DEN-2 gp 58 protein were also revealed in this experiment. The more-effective competition by DEN-3 gp 58 protein than by Anti-Nakayama Virus Serum SLE clearly indicated the presence of dengue complex-specific determinants. The same competition curves give evidence that DEN-2 typespecific antigens are also present; greater amounts of DEN-3 than DEN-2 were required for the competition, and even high concentrations of DEN-3 gp 58 protein failed to compete for all of the antibodies binding the DEN-2 protein.
All of the envelope glycoproteins used in the dengue virus experiments were examined in the heterologous assay system for the presence of group-reactive antigens. There were no differences in the competition of the four dengue serotypes in their reaction with antibodies in the SLE serum (Fig. 8B) and nucleocapsid proteins (13) . Treatment ofJE virus with SDS destroyed hemagglutinating activity; however, the isolated glycoprotein was reactive by CF and immunodiffusion (13) . Concanavalin A chromatography of detergent-solubilized antigen separated a form of DEN gp 58 that antigenically did not bind neutralizing antibody and reacted as a type-specific antigen by CF (34) . Isoelectric focusing of flaviviral proteins that had been solubilized with nonionic detergent facilitated the isolation of purified antigens that biologically and antigenically are like intact virions, bind to erythrocytes, react by CF, immunoprecipitate, and are immunologically reactive in the solid-phase radioimmunoassay.
The observation that the envelope glycoprotein of flaviviruses contains at least three different antigenic determinants indicates that these proteins are immunologically complex. The antigenic cross-reactivity of isolated JE gp 58 and SLE gp 53 proteins by CF and immunodiffusion was reported previously (13, 26, 27) . From our radioimmunoassay data, we previously suggested that the envelope glycoprotein contains group-reactive and type-specific antigens (38) . Westaway et al. (40, 43) used different techniques, and-their results also suggested that the surface glycoproteins have multiple antigenic sites. JE and dengue virus soluble complement-fixing nonstructural proteins contain both group-reactive and type-specific antigenic determinants (3, 13, 28) .
From the data reported here it can be assumed that the differences in the amounts of competing protein required for 50% maximal competition are proportional to differences in the concentration of different antigens rather than differences in the affinity of (4, 45) . These data suggest that El alaphavirus protein has both type-specific and complex-reactive antigens. The envelope glycoprotein and nucleocapsid proteins of SLE, dengue, and JE viruses share at least one common group antigen as measured by competition radioimmunoassay and immunodiffusion (13) . The group determinants on these two proteins are probably responsible for the broad serological cross-reactivity observed upon repeated immunization or after multiple flavivirus infections (6, 7, 9, 16, 17, 37, 43, 44) . Nucleoproteins of the alphaviruses (10, 11) , influenzavirus (21, 30) , and rabies group viruses (31), like the flaviviruses, contain group-reactive determinants.
The presence of complex-reactive and typespecific antigens on the flaviviruses glycoprotein explains the serological complexity of the immune response. Neutralizing antibody induced by the flavivirus glycoprotein is produced to the type antigen and is expressed in the HI reaction (7-9, 16, 17) . Infection with one member of a complex induces complex-reactive HI antibodies, which do not provide immunity to infection with a second member of the complex (29, 40, 44) . Adsorption of sera with a heterologous antigen makes the HI reaction type specific (8, 9, 16, 17 (16, 17, 24, 25) . Our studies with strains of JE virus confirm earlier antibody adsorption and HI and CF immunotyping of these strains (17, 24, 25) and clearly show variations within the JE typespecific determinants (25) . The structures of alphavirus and flavivirus envelopes are obviously quite different. The alphavirus membrane contains two surface glycoproteins distinctly different immunologically, chemically, and biologically (10, 11) . The flavivirus envelope contains only one glycoprotein on its surface, which has multiple antigenic determinants and biological functions (19, 25-27, 33, 35, 39, 41-43) . The diversity in alphavirus and flavivirus virion structure reflects basic differences in the mechanisms of viral-directed biosynthesis and morphogenesis. We are currently investigating the immunological specificities of the flavivirus proteins and the structural relationships of the envelope glycoproteins. 
